EXCEL Clinical Trial Full Text View - ClinicalTrials.gov. EXCEL Clinical Trial 10-389 Evaluation of XIENCE PRIME or.
of Left Main Revascularization (EXCEL) trial has been reported previously.8 In brief, EXCEL was an international, open-label, multicenter randomized trial that compared everolimus-eluting stents. This certificate is delivered in PDF format for you to print. It’s Internationally recognized and demonstrates to future employers that you have a high proficiency in Excel. It’s Internationally recognized and demonstrates to future employers that you have a high proficiency in Excel..
We therefore examined the outcomes of patients with left main coronary artery disease (LMCAD) with and without CKD randomized to PCI with everolimus eluting-stents (EES) versus CABG in the EXCEL (Evaluation of XIENCE Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) trial . EXCEL (Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) was an international, open-label, multicenter randomized trial that compared everolimus-eluting stents with coronary-artery bypass grafting (CABG) in patients with left main …
A Brief Update of PCI for Left Main Disease Perspectives After the EXCEL and NOBLE Trials Gregg W. Stone MD Columbia University Medical Center NewYork-Presbyterian Hospital. of trial • Differences with EXCEL partly explained by different MI definition, inclusion repeat revascularization and focus on longer follow up. Bottom Line NOBLE • More thrombosis in NOBLE with SES/BES than in EXCEL with EES: need stratified analysis with stent type • SYNTAX score results at odds with current guidelines. Bottom bottom line • New left main recommendations to be patient.
“EXCEL substudy PCI confers similar QOL status to CABG in”.
Journals JAMA JAMA Network myocardial infarction, or stroke. In influence analysis, the Nordic-Baltic-British Left Main Revascularisation (NOBLE) trial 8 introduced heterogeneity. In drug-eluting stent (DES) generation, results were not significantly influenced when trials were grouped according to drug-eluting stent generation. In anatomic complexity, results also were not significantly.
in the SYNTAX trial, only 705 patients with left main coronary artery disease were included. Although, the randomised trials suggested that PCI was a valid alternative to CABG, we found a need for further documentation with a large randomised trial. Added value of this study. Our findings of similar mortality but higher rates of myocardial infarction and repeat revascularisation in patients. The results of this trial are in discordance with the larger EXCEL trial, which showed noninferiority between PCI and CABG for left main lesions. The event rates in this trial are higher in the PCI arm than those noted in the EXCEL trial, despite enrolling a lower-risk population (80% stable angina, median SYNTAX score 22.5).. Coronary Artery Bypass Grafting Versus Drug Eluting Stent Percutaneous Coronary Angioplasty in the Treatment of Unprotected Left Main Stenosis. In a clinical, randomized, 5-year follow-up study to compare essential clinical outcome parameters in patients with unprotected left main (LMCA) disease.